Clinical Trials Browser

Has results × Glioma × Everolimus × Clear all

NCT03834740 2025-05-30

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

Phase EARLY_PHASE1 Completed

27 enrolled 17 charts

Brain Neoplasms, Glioblastoma, Glioma

NCT03245151 2023-08-30

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

Phase 1/2 Completed

64 enrolled 29 charts

Glioma, Recurrence, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT03387020 2021-08-27

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Phase 1 Completed

22 enrolled 16 charts

Familial ependymoma, Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma, Rhabdoid Tumor

NCT00823459 2020-07-28

Everolimus in Treating Patients With Recurrent Low-Grade Glioma

Phase 2 Completed

58 enrolled 10 charts

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma

NCT01158651 2020-02-05

NFC-RAD001

Phase 2 Completed

23 enrolled 11 charts

Glioma

NCT00782626 2018-08-15

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Phase 2 Completed

23 enrolled 6 charts

Astrocytoma, Glioma